Tri-2-cresyl phosphate (TOCP) has long been known to cause delayed neurotoxic effects in man as well as in cat and hen. Characteristically weakness of limbs and ataxia develop 8-14 days after dosing and there is little recovery. Axonal degeneration rather similar to wallerian degeneration is seen in long axons of spinal cord and peripheral nerves and has been described by Cavanagh (1964) as 'dying-back'. Similar effects are known to be produced by a variety of organophosphorus esters and the general background of the problem has been recently surveyed (Johnson 1969a) . The relationship of the lesion to other toxic neuropathies and some clinical conditions has been discussed by Cavanagh (1969) .
To understand the mechanism of action of a toxic substance one may either concentrate on identifying the region of disturbed metabolism or attempt to trace the initial site of reaction in terms of chemistry and enzymology. Early approaches to the problem of delayed neurotoxicity concentrated on lipid metabolism on the mistaken premise that the lesion was primarily demyelination but no clear defect was found. It was pointed out (Aldridge 1954 ) that all the agents were active inhibitors of esterases or were converted to such in vivo. Various esterases have been considered as the primary target in the genesis of the lesion but have been rejected.
My work has been based on the simple proposition that all neurotoxic organophosphorus compounds react to form a stable covalent chemical bond with a specific site in the nervous system. There is no necessity to assume anything about the nature of this site although the possibility of it being an esterase enzyme seemed high. A further simplifying factor for initial experiments was the proposition that brain, spinal cord and peripheral nerves all possessed such a site. The absence of lesions from the brain might then only reflect the fact that long axons have special difficulty in maintaining their integrity when the metabolic apparatus of the whole nervous system is maltreated. In order to identify the site I used a radiolabelled neurotoxic organophosphorus compound (di-isopropyl phosphorofluoridate, DFP). This, however, is not very specific when used alone and was found to react covalently with many proteins in hen brain in vivo and in vitro. By careful study of the reaction in vitro it has been found possible to screen out many of these sites of reaction and to identify a specific site which is always phosphorylated in vivo when neurotoxic esters are administered to hens (Johnson 1969b) . This site has been identified as having esterase activity (Johnson 1969c) and if it is temporarily carbamylated or sulphonated in vivo then doses of TOCP or other neurotoxic esters produce no lesions (Johnson & Lauwerys 1969 , Johnson 1970 . It is interesting that study of the biochemical properties of brain has provided an entirely satisfactory monitor of the initial event leading to dyingback of long axons. The 'neurotoxic esterase' has been found also in homogenates of spinal cord and sciatic nerve and it responds to neurotoxic compounds in the same way as the brain enzyme. It appears that the enzyme is common to all neurones but it has not been detected in other organs. Recent work (Johnson 1970) has shown that the toxic effect is due not to the loss of esterase activity per se but to loss of some other function of the esterase protein molecule when it is phosphorylated. It is hoped that comparison of the behaviour of the purified site protein when it is phosphorylated or sulphonated in vitro may lead to further understanding of the whole disturbed process which leads to degeneration of the axon. Botulinum toxin exerts its effects on the nervous system in a highly specific manner. In both voluntary and autonomic systems transmission at cholinergic nerve terminals is blocked, causing flaccid paralysis of skeletal muscle and parasympathetic failure. If an injection of botulinum toxin is made directly into a muscle of an experimental animal it is possible to study the effects of the toxin through successive stages of paralysis and recovery, provided that the dose of toxin is small enough to cause only local effects and the animal can survive the transient general toxic effects. In the experiments which I have carried out a sublethal dose of Type A botulinum toxin was injected into calf muscles of one hindleg in mice. Within about twentyfour hours the muscles of the leg became paralysed and recovered only after several weeks (Duchen & Strich 1968 ). This paper is concerned with changes which take place in the motor nerves of the affected muscles since it seems that these changes are the means by which function is restored.
For the first few days after the onset of muscle paralysis no abnormalities were found in the motor nerve terminals or in myelinated preterminal nerve fibres with either light or electron microscopy. The first light microscopic changes in the morphology of motor nerves were found in the slow (red) soleus 6-7 days after the injection of toxin (Duchen 1970a), but were seen after four days with the electron microscope (Duchen 1971) . It was found that axonal sprouts grew out from the intact nerve terminals in the motor end-plates. For several weeks these motor nerve sprouts grew along and branched across the muscle fibres which became progressively more atrophied. With electron microscopy it was found that the sprouting axons were wrapped in processes of Schwann cells which were interposed between axolemma and sarcolemma, and the sarcolemma showed no subneural folds. Enzyme histochemical studies showed that while true (acetyl) cholinesterase was localized to the subneural folds of the original end-plates, pseudo (butyryl) cholinesterase was found along the axonal sprouts mainly between axon and Schwann cells. The growing axons contained neurofilaments, mitochondria and vesicles. About two to three weeks after the commencement of nerve sprouting in soleus, the muscle fibres were no longer paralysed and again increased in size. At this time motor nerve growth ceased and electron microscopy showed that close contacts between axolemma and sarcolemma were formed at which vesicles became aggregated. No subneural folds were present at these new neuromuscular junctions and it took several more weeks before shallow and irregular folds were formed. Over the next few months the subneural folds became steadily more like the normal. The new neuromuscular junctions were irregular in size and abnormal in distribution, being scattered along muscle fibres randomly. In the superficial part of the gastrocnemius which contains fast (white) muscle fibres, the axonal sprouting began about three to four weeks after the injection of the toxin (several weeks later than in soleus), but once the sprouting had commenced the sequence of events was similar in the two muscles. However, the muscle fibres of gastrocnemius became more severely atrophied than those of soleus, probably because of the prolonged delay in the onset of nerve sprouting and in the formation of new neuromuscular junctions.
In other experiments (unpublished) the effect of varying the dose of toxin was investigated. Three different doses of toxin, each contained in the same volume of buffer, were injected. The highest dose was approximately at the LD50 level while the lowest dose was one-twentieth of that level. The higher the dose of toxin the more severe was the degree of paralysis and atrophy and the more profuse and extensive was the nerve sprouting.
Further experiments were carried out to study the effect of nerve crush and regeneration on the innervation of muscles paralysed by
